Vanda Pharmaceuticals Inc.

VNDA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$102,316$135,821$135,029$52,071
Short-Term Investments$272,327$252,443$331,830$380,742
Receivables$47,101$34,155$33,512$32,467
Inventory$1,726$1,357$1,194$1,025
Other Curr. Assets$15,420$9,170$17,727$11,996
Total Curr. Assets$438,890$432,946$519,292$478,301
Property Plant & Equip (Net)$12,677$9,140$10,973$12,385
Goodwill$0$0$0$0
Intangibles$114,096$121,369$18,565$20,081
Long-Term Investments$0$0$0$0
Tax Assets$81,440$75,000$74,039$74,878
Other NC Assets$9,101$9,985$11,378$8,147
Total NC Assets$217,314$215,494$114,955$115,491
Other Assets$0$0$0$0
Total Assets$656,204$648,440$634,247$593,792
Liabilities
Payables$3,498$7,145$12,690$925
Short-Term Debt$4,270$2,398$2,328$2,311
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$92,213$78,154$76,418$71,183
Total Curr. Liab.$99,981$87,697$91,436$74,419
LT Debt$8,090$7,006$8,813$10,055
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$9,587$8,827$6,800$4,390
Total NC Liab.$17,677$15,833$15,613$14,445
Other Liabilities$0$0$0$0
Cap. Leases$12,360$9,404$11,141$12,366
Total Liabilities$117,658$103,530$107,049$88,864
Equity
Pref Stock$0$0$0$0
Common Stock$58$58$57$56
Retained Earnings-$174,292-$155,392-$157,901-$164,176
AOCI$74-$30-$1,193-$175
Other Equity$712,706$700,274$686,235$669,223
Total Equity$538,546$544,910$527,198$504,928
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$656,204$648,440$634,247$593,792
Net Debt-$89,956-$126,417-$123,888-$39,705
Vanda Pharmaceuticals Inc. (VNDA) Financial Statements & Key Stats | AlphaPilot